Luteolin.

Luteolin and quercetin are both flavonoids that stabilize mast cells and damp the release of histamine and other inflammatory mediators, so pairing them supports a calm, balanced histamine and immune response through the same well-characterized pathway. Their overlapping antioxidant action also lets each spare the other as free-radical scavengers.

When luteolin neutralizes a free radical it becomes a spent flavonoid radical, and ascorbate donates an electron to regenerate it back to the active form. This recycling is settled phenolic redox chemistry and keeps the body's normal antioxidant defenses working longer than either compound alone.

Apigenin and luteolin are closely related flavones that differ by a single hydroxyl group and co-occur in the same plants such as chamomile and parsley, so they act on overlapping antioxidant and mast-cell pathways. Combining them broadens coverage of the same normal inflammatory-balance mechanism.

Both flavonoids are heavily glucuronidated and sulfated by overlapping UGT and SULT isoforms on first pass. Co-dosing loads those enzymes, which raises the free fraction of each.

Baicalein is a close flavone relative that competes for the same glucuronidation route as luteolin. The gut wall handles the two as one substrate pool, so conjugation capacity is shared.

Piperine inhibits intestinal UGT activity and some CYP isoforms, the main clearance route for flavones. Adding it to a luteolin dose raises and lengthens plasma exposure.

Curcumin and luteolin are both cleared mainly by glucuronidation and both damp NF-kB driven signalling in normal inflammatory tone. The shared clearance route means each raises the other's free fraction.

Resveratrol saturates SULT1A1 at ordinary supplement doses, and luteolin is a substrate of the same enzyme. Taken together, less of each is sulfated on first pass.

The catechol group on luteolin binds ferric iron in the gut lumen and forms a poorly absorbed complex. An iron dose taken in the same window shows lower uptake, so the two belong at separate times.

Flavonoid hydroxyl groups coordinate divalent cations including zinc, which lowers the free ion available to transporters. Separating the doses keeps mineral uptake intact.

Flavonoids can hand an electron to the tocopheroxyl radical formed when vitamin E quenches a lipid radical, returning vitamin E to its active form. That regeneration step is why the two are formulated together in lipid systems.

Catechins and luteolin are both COMT substrates and both ride the same MRP efflux pumps out of the enterocyte. Competition at those steps raises the circulating fraction of each.

Luteolin scavenges radicals directly through its catechol B ring, while glutathione is the cell's main thiol buffer and regenerates other oxidised antioxidants. Animal work with luteolin routinely reports higher tissue glutathione and lower malondialdehyde alongside it. Those are oxidative-stress markers measured in tissue, not clinical outcomes in people.

NAC supplies cysteine, the rate-limiting substrate for glutathione synthesis. Pairing it with a flavone that spares glutathione puts one ingredient on the supply side and the other on the demand side of the same thiol pool. The rationale is mechanistic; no trial of the two together in people is cited here.

Alpha-lipoic acid cycles between dithiol and disulfide forms and helps regenerate ascorbate and glutathione. Luteolin partitions into membranes and quenches radicals where lipids sit. The two occupy different compartments of the same antioxidant network, which is why formulators place them together.

Sulforaphane modifies Keap1 cysteines and drives Nrf2-dependent transcription of phase II enzymes. Luteolin also raises antioxidant-enzyme expression in animal tissue. Both act on the induction side of endogenous defence rather than by donating electrons themselves, so the pairing is about the same transcriptional programme reached by two chemistries.

Rutin and luteolin are both handled by intestinal and hepatic UGT and SULT enzymes, and flavonoids compete for that limited conjugating capacity. Taken together at high amounts, each can raise the unconjugated fraction of the other. This is a pharmacokinetic interaction, not a claim that either does more in the body.

Silymarin flavonolignans inhibit UGT1A1 and several sulfotransferases in laboratory systems, the same routes that clear luteolin. Co-dosing can slow luteolin conjugation and shift its plasma profile. Read it as a kinetic interaction worth knowing when both sit in one capsule.

The 3',4'-dihydroxy arrangement on luteolin's B ring binds divalent transition metals, copper included. Bound copper is less available for absorption and less able to drive Fenton chemistry. Separating a copper-containing multivitamin from a high-dose flavone by a couple of hours is ordinary formulation practice.

Manganese is a divalent cation and flavone catechols coordinate it in solution. The complex is poorly absorbed compared with the free mineral. The interaction is about timing of intake, not about either ingredient being unsuitable.

Luteolin aglycone is close to insoluble in water, and dissolution is the step that limits how much reaches the gut wall. Phospholipids form mixed micelles that keep it dispersed through the small intestine. Phytosome-style phospholipid complexes are built on exactly this principle.

Medium-chain triglycerides carry lipophilic actives into the micellar phase and are the usual fill for a flavone softgel. The oil does not change what luteolin does; it changes how much of it stays dissolved long enough to be taken up. Fill choice is a formulation decision, not a quality ranking.

Most dietary luteolin arrives as luteolin-7-O-glucoside, and colonic bacteria cleave the sugar to release the absorbable aglycone. People differ widely in that capacity because they differ in the organisms they carry. A live-culture product is proposed here on that mechanism, not on a trial of the pair.

Inulin is fermented by bifidobacteria and related genera in the colon, the same community that hydrolyses flavonoid glycosides. Feeding that community is a plausible way to support conversion of luteolin glycosides. The link is mechanistic and has not been measured for luteolin specifically here.

Pterostilbene is the dimethylated stilbene analogue of resveratrol and, like luteolin, acts in the membrane compartment. Both are cleared partly by COMT and sulfotransferases, so heavy co-dosing loads the same routes. The pairing is common in polyphenol blends and rests on chemistry rather than on a combination trial.